Market
Roche to acquire PathAI in $1.05bn deal
Roche signed a definitive merger agreement to acquire PathAI for up to $1.05 billion. PathAI develops AI-powered digital pathology software for analyzing histopathology images. The acquisition expands Roche's diagnostics and AI capabilities in pathology and precision medicine.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network